This is a good find Vulcarum. The fact that Teva is launching it's smart inhaler now to the UK general market even without reimbursements like the US is offering is a very positive sign for Adherium's UK operation. Teva would have done it's home work first before making this decision. I don't see any mention of how they plan to integrate their product. Maybe keeping that info close to their chest.
Very interesting article, page-258
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
